Marvell Technology (NASDAQ:MRVL) EVP Sells $755,205.00 in Stock

Marvell Technology, Inc. (NASDAQ:MRVL) EVP Mark Casper sold 6,900 shares of the stock in a transaction dated Monday, April 6th. The shares were sold at an average price of $109.45, for a total transaction of $755,205.00. Following the completion of the sale, the executive vice president owned 10,263 shares of the company’s stock, valued at approximately $1,123,285.35. This trade represents a 40.20% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Mark Casper also recently made the following trade(s):

• On Thursday, April 2nd, Mark Casper sold 10,854 shares of Marvell Technology stock. The shares were sold at an average price of $107.01, for a total transaction of $1,161,486.54.
• On Wednesday, April 1st, Mark Casper sold 7,000 shares of Marvell Technology stock. The shares were sold at an average price of $105.11, for a total transaction of $735,770.00.

Marvell Technology Stock Performance

Shares of MRVL stock traded down $0.29 during trading hours on Tuesday, hitting $109.22. 15,004,896 shares of the company were exchanged, compared to its average volume of 18,283,549. The firm has a fifty day simple moving average of $85.95 and a 200 day simple moving average of $86.00. The company has a current ratio of 2.01, a quick ratio of 1.58 and a debt-to-equity ratio of 0.28. Marvell Technology, Inc. has a 52-week low of $48.09 and a 52-week high of $111.89. The stock has a market capitalization of $95.51 billion, a price-to-earnings ratio of 35.46, a P/E/G ratio of 0.97 and a beta of 1.83.

Marvell Technology (NASDAQ:MRVL) last issued its quarterly earnings results on Thursday, March 5th. The semiconductor company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.01. Marvell Technology had a net margin of 32.58% and a return on equity of 14.22%. The company had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.21 billion. During the same quarter last year, the business posted $0.60 EPS. Marvell Technology’s quarterly revenue was up 22.1% compared to the same quarter last year. Marvell Technology has set its Q1 2027 guidance at 0.740-0.840 EPS. Research analysts predict that Marvell Technology, Inc. will post 0.91 earnings per share for the current fiscal year.

Marvell Technology Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Friday, April 10th will be paid a dividend of $0.06 per share. The ex-dividend date is Friday, April 10th. This represents a $0.24 annualized dividend and a dividend yield of 0.2%. Marvell Technology’s dividend payout ratio (DPR) is presently 7.79%.

More Marvell Technology News

Here are the key news stories impacting Marvell Technology this week:

• Positive Sentiment: NVIDIA’s $2 billion investment and deeper NVLink Fusion tie-up elevates Marvell’s strategic position in AI scale‑up networking, expands go‑to‑market support, and materially boosts Marvell’s cash runway — a clear driver behind the recent rally. NVIDIA AI ecosystem expands as Marvell joins forces through NVLink Fusion
• Positive Sentiment: Unusual in‑the‑money options activity accompanied the post‑NVIDIA move and has been interpreted by some traders as bullish positioning ahead of further AI‑driven demand for Marvell’s chips and interconnect products. Marvell Technology Stock Surges on Nvidia Investment, Sparking Huge Unusual Options Trades
• Positive Sentiment: Recent fundamental backdrop remains supportive: Marvell reported a modest earnings beat and revenue growth earlier this year and has benefited from a strong March share gain narrative that analysts highlight as indicating further upside potential. Marvell Technology Stock (MRVL) Surges 24% in March — Is 50% Upside Still Ahead?
• Neutral Sentiment: MarketBeat’s roundup (“Bridget’s Buys”) lists Marvell among more durable tech names in a speculative watchlist — a framing that can attract retail interest but isn’t a company‑specific catalyst. Bridget’s Buys
• Neutral Sentiment: Be aware of a same‑ticker name: Marvel Biosciences (TSXV: MRVL) announced funding for a clinical trial — this is unrelated to Marvell Technology (NASDAQ: MRVL) but can create ticker confusion in news feeds. Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
• Negative Sentiment: Insider selling: reports show Marvell insiders (including David Casper and COO Chris Koopmans) sold shares in early April. While Koopmans’ trade was under a pre‑arranged 10b5‑1 plan (reducing interpretive weight), serial insider sales can fuel near‑term profit‑taking narratives. Marvell Insider David Casper Just Sold Nearly 18,000 Shares of MRVL Stock. Should You Sell Too?
• Negative Sentiment: COO Chris Koopmans disclosed a 10,000‑share sale (filed with the SEC); even if planned, such filings can stoke short‑term selling pressure. Chris Koopmans

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Laurel Wealth Advisors LLC bought a new position in Marvell Technology in the 4th quarter worth approximately $25,000. Jessup Wealth Management Inc bought a new position in Marvell Technology in the 4th quarter valued at $25,000. Cherry Tree Wealth Management LLC bought a new position in Marvell Technology in the 4th quarter valued at $26,000. Atlantic Edge Private Wealth Management LLC boosted its holdings in Marvell Technology by 160.0% in the 3rd quarter. Atlantic Edge Private Wealth Management LLC now owns 325 shares of the semiconductor company’s stock valued at $27,000 after purchasing an additional 200 shares during the period. Finally, MidFirst Bank bought a new position in Marvell Technology in the 4th quarter valued at $28,000. 83.51% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on MRVL. Evercore restated an “outperform” rating and set a $133.00 price target on shares of Marvell Technology in a research note on Wednesday, March 4th. Craig Hallum raised their price target on shares of Marvell Technology from $141.00 to $164.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Needham & Company LLC decreased their price target on shares of Marvell Technology from $120.00 to $118.00 and set a “buy” rating for the company in a research note on Tuesday, February 3rd. Citigroup raised their price target on shares of Marvell Technology from $113.00 to $118.00 and gave the stock a “buy” rating in a research note on Friday, March 6th. Finally, UBS Group raised their price target on shares of Marvell Technology from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Two investment analysts have rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $117.24.

Marvell Technology Company Profile

Marvell Technology Group is a global semiconductor company that designs and develops integrated circuits and related software for data infrastructure, networking, storage and connectivity markets. The company’s product portfolio includes system-on-chip (SoC) solutions, Ethernet physical-layer transceivers (PHYs), switch and switch silicon, optical interconnect components, storage controllers, and security processors. Marvell’s technology is used to enable high-performance data centers, carrier networks, enterprise and cloud storage, as well as connectivity in automotive and industrial applications.

Founded in 1995 and headquartered in Santa Clara, California, Marvell has grown through both organic development and strategic acquisitions to broaden its capabilities across networking and data interconnect.